Veltist
Z├╝rich
About Veltist
Veltist, a Swiss medtech startup spun out of ETH Zurich and Empa, and developing an advanced sealant patch’AnastoSEAL, designed to eliminate post-surgical digestive fluid leaks, a complication that affects over 10% of the 14 million annual abdominal surgery patients worldwide.
Company Facts
- Operating status: Active
- IPO status: Private
- Employees: 1 – 10
- Total funding: $181.8K
- Last round: Grant (May 2025)
- Website: veltist.com
Industries & Categories
Medical Device
Social Profiles
Canonical: https://fsome.com/organization/veltist-153322 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.